Nano-X Imaging Expands Nanox.ARC Distribution in New England Through Partnership with Associated X-Ray Imaging Corp.

In a strategic move to broaden the reach of its innovative imaging technology, Nano-X Imaging (NASDAQ: NNOX) has announced a new distribution agreement through its U.S. subsidiary, Nanox Impact Inc., with Associated X-Ray Imaging Corp. The partnership is designed to support the deployment of the Nanox.ARC, an FDA-cleared, multisource 3D digital tomosynthesis system, across New England. Under the terms of the agreement, Associated X-Ray Imaging will be responsible for marketing, distributing, and supporting the system, leveraging its established regional customer relationships and service infrastructure.

This expansion is a significant step for Nano-X Imaging as it continues to build its U.S. channel partner network. The primary goal is to increase the accessibility of the Nanox.ARC in outpatient and community-based clinical settings, which could lead to earlier detection of diseases and improved patient outcomes. The Nanox.ARC is designed to be a cost-effective, scalable imaging solution that can operate beyond traditional hospital environments, aligning with the company's vision to democratize medical imaging.

Nanox's broader ecosystem includes Nanox.AI, a suite of AI algorithms that enhance the interpretation of CT imaging to identify early signs of chronic disease; Nanox.CLOUD, a secure cloud platform for data management and analytics; and Nanox.MARKETPLACE, which provides access to remote radiology and cardiology experts. The integration of these technologies aims to streamline workflows and support preventive care on a wider scale.

The agreement with Associated X-Ray Imaging is expected to capitalize on the company's local knowledge and service capabilities, potentially accelerating adoption of the Nanox.ARC in the region. This move could also influence the competitive landscape of medical imaging by offering an alternative to traditional, higher-cost systems, especially in community healthcare settings where access to advanced imaging is often limited.

Industry analysts suggest that this distribution expansion may signal growing confidence in the Nanox.ARC's commercial viability. By partnering with regional distributors, Nano-X is strategically positioning itself to penetrate markets that have been historically underserved by advanced imaging technologies. This could have long-term implications for preventive healthcare, as the system's 3D tomosynthesis capabilities may enable earlier detection of conditions such as cardiovascular disease and certain cancers.

For more information on this announcement, you can view the full press release at https://nnw.fm/ChGtd. Additionally, the latest news and updates regarding Nano-X Imaging are available in the company's newsroom at https://ibn.fm/NNOX.

As Nano-X Imaging continues to expand its footprint, the success of this distribution agreement could serve as a model for future partnerships in other regions, potentially reshaping how imaging services are delivered across the United States. The move underscores the company's commitment to making advanced diagnostic tools more accessible, which could ultimately lead to better health outcomes and more efficient healthcare delivery.